<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">PVS</journal-id>
<journal-id journal-id-type="hwp">sppvs</journal-id>
<journal-id journal-id-type="nlm-ta">Perspect Vasc Surg Endovasc Ther</journal-id>
<journal-title>Perspectives in Vascular Surgery and Endovascular Therapy</journal-title>
<issn pub-type="ppub">1531-0035</issn>
<issn pub-type="epub">1521-5768</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage CA: Los Angeles, CA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/1531003512459913</article-id>
<article-id pub-id-type="publisher-id">10.1177_1531003512459913</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Featured Articles</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Long-Term Results of Carotid Artery Stenting in Patients 80 Years and Older</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name><surname>Mazzaccaro</surname><given-names>Daniela</given-names></name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff1-1531003512459913">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Occhiuto</surname><given-names>Maria Teresa</given-names></name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff1-1531003512459913">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Stegher</surname><given-names>Silvia</given-names></name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff1-1531003512459913">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Malacrida</surname><given-names>Giovanni</given-names></name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff1-1531003512459913">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Caldana</surname><given-names>Marco</given-names></name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff1-1531003512459913">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Tealdi</surname><given-names>Domenico G.</given-names></name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff1-1531003512459913">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Nano</surname><given-names>Giovanni</given-names></name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff1-1531003512459913">1</xref>
</contrib>
</contrib-group>
<aff id="aff1-1531003512459913"><label>1</label>Università degli Studi di Milano, IRCCS Policlinico S. Donato, San Donato Milanese, Milan, Italy</aff>
<author-notes>
<corresp id="corresp1-1531003512459913">Daniela Mazzaccaro, MD, IRCCS Policlinico S. Donato, Piazza E. Malan 1, 20097 San Donato Milanese, Milan, Italy Email: <email>danymazzak83@libero.it</email></corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>6</month>
<year>2012</year>
</pub-date>
<volume>24</volume>
<issue>2</issue>
<fpage>49</fpage>
<lpage>54</lpage>
<permissions>
<copyright-statement>© The Author(s) 2012</copyright-statement>
<copyright-year>2012</copyright-year>
<copyright-holder content-type="sage">SAGE Publications</copyright-holder>
</permissions>
<abstract>
<p><italic>Introduction</italic>. We report our experience about carotid artery stenting (CAS) in patients 80 years and older. <italic>Materials and Methods</italic>. Out of 582 patients who underwent CAS at our institution from January 1999 to June 2010, 102 patients (group A) were 80 years or older. The clinical data of these patients were retrospectively reviewed, outcomes analyzed, and compared with those of younger patients who underwent CAS during the same period (group B). <italic>Results</italic>. Outcomes of group B were similar to those of group A, both at 30 days and at long term. Male gender, symptoms, and not using an embolic protection device were related to long-term complications in both groups. Occurrence of bradycardia/asystole during CAS was a risk factor for long-term myocardial infarction for group A only. <italic>Conclusions</italic>. CAS can be safely performed in patients 80 years or older, with results that compare favorably to those of younger patients.</p>
</abstract>
<kwd-group>
<kwd>carotid artery stenting</kwd>
<kwd>80 years old</kwd>
<kwd>long-term results</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="section1-1531003512459913" sec-type="intro">
<title>Introduction</title>
<p>The increase in population of the elderly and increased life expectancy have changed the attitude of the vascular surgeons who tend to be today less conservative and more aggressive with treatment of patients 80 years age or older. This is also true for carotid artery disease.<sup><xref ref-type="bibr" rid="bibr1-1531003512459913">1</xref></sup>
</p>
<p>However, older patients more likely present with more comorbidities and thus represent a greater surgical risk than the younger ones. Endovascular option, therefore, was proposed as a better alternative to traditional surgery in this high-risk and elderly patients.<sup><xref ref-type="bibr" rid="bibr2-1531003512459913">2</xref></sup> Data emerging from the literature, however, are not unanimous concerning short- and long-term results of carotid artery stenting (CAS) in elderly patients.<sup><xref ref-type="bibr" rid="bibr3-1531003512459913">3</xref></sup>
</p>
<p>We report our experience in a nonrandomized single-center retrospective study on CAS in patients 80 years and older.</p>
</sec>
<sec id="section2-1531003512459913" sec-type="materials|methods">
<title>Materials and Methods</title>
<p>From January 1999 to June 2010, 582 patients with a significant carotid artery stenosis underwent CAS at our institution. Of them, 102 patients were 80 years or older (group A), whereas the remaining 480 patients were younger than 80 years (group B).</p>
<p>Age alone was not an indication for performing CAS. In fact, if a patient is suitable for open surgery, we perform carotid endarterectomy as the treatment of choice. We usually do not perform CAS in case of severe tortuosity or calcification of the aortic arch or the supra-aortic vessels, in cases with soft or hemorrhagic carotid plaque, carotid occlusion or thrombosis, severe renal impairment, if major stroke occurred in the previous 3 weeks, in the presence of concomitant thoracic or abdominal aortic aneurysm, or in the presence of any contraindications to antiplatelet agents.</p>
<p>All patients underwent preoperative carotid artery duplex ultrasound evaluation and some of them underwent a preoperative magnetic resonance angiography or computed tomography angiography imaging to evaluate the aortic arch, the carotid stenosis, and the intracranial circulation.</p>
<p>Aspirin and clopidogrel orally were started at least 24 hours before the procedure, in some patients, aspirin and ticlopidine at least 5 days before stenting. Then ticlopidine (250 mg twice daily) or clopidogrel (75 mg daily) were continued for 1 month after revascularization followed by aspirin (100 mg daily) lifelong.</p>
<p>All procedures were performed in the operating suite by a vascular surgeon, with attended local anesthesia, with anesthesiological assistance, and all patients were awake during the procedure.</p>
<p>In the first year of our experience, embolic protection devices were not routinely used, and they were employed whenever possible.</p>
<p>Primary stenting was performed whenever possible. Postdilatation was achieved using 4.5-6.0 × 20 mm balloons; atropine was selectively administered in patients with bradycardia (a decrease in heart rate to &lt;50% or an absolute heart rate of &lt;40 bpm) or hypotension (systolic blood pressure &lt;90 mmHg) at insufflation of the balloon or at deployment of the stent.<sup><xref ref-type="bibr" rid="bibr4-1531003512459913">4</xref></sup> As for the access site, manual compression on arterial access was preferred; vascular closure device (Angio-Seal, St Jude Medical, St Paul, MN) was employed when patients were on oral anticoagulation.</p>
<p>At discharge and at 1, 3, 6, and 12 months after the procedure and annually afterward, all patients underwent a clinical examination by a vascular surgeon and carotid duplex ultrasound evaluation was performed to assess stent patency and clinical status; we documented death, major cerebrovascular adverse events (minor/major stroke), and major cardiovascular adverse events at 30 days. At long term we documented any death, major cerebrovascular adverse events (minor/major stroke), major cardiovascular adverse events, and in stent-restenosis. When neurological symptoms occurred, evaluation was performed by a neurologist.</p>
<p>According to guidelines of the National Institutes of Health (NIH), a minor stroke was classified as a new neurologic event that resulted in slight impairment of neurologic function (speech, motor, or sensory skills), which either completely resolved within 7 days or caused an increase in the NIH stroke scale of less than 4.<sup><xref ref-type="bibr" rid="bibr5-1531003512459913">5</xref></sup> A major stroke was defined as a new neurological deficit that persisted after 7 days and increased the NIH stroke scale score by 4 or more.<sup><xref ref-type="bibr" rid="bibr5-1531003512459913">5</xref></sup> Stent-restenosis was considered severe in case of a vessel diameter reduction of more than 70%.<sup><xref ref-type="bibr" rid="bibr6-1531003512459913">6</xref>,<xref ref-type="bibr" rid="bibr7-1531003512459913">7</xref></sup>
</p>
<p>Statistical analysis was performed using JMP 5.1. <italic>P</italic> values of ≤.05 were considered statistically significant. χ<sup>2</sup> tests, log-rank tests, Wilcoxon tests, and Kaplan–Meier survival analysis were performed.</p>
</sec>
<sec id="section3-1531003512459913" sec-type="results">
<title>Results</title>
<p>Of 582 patients with a significant carotid stenosis who underwent CAS, 102 (17.5%) were 80 years or older. The patients’ median age was 82.5 years (range 80.0-99.7 years). Clinical features of patients in both groups A and B are shown in <xref ref-type="table" rid="table1-1531003512459913">Table 1</xref>.</p>
<table-wrap id="table1-1531003512459913" position="float">
<label>Table 1.</label>
<caption>
<p>Patients’ Features of Groups A and B</p>
</caption>
<graphic alternate-form-of="table1-1531003512459913" xlink:href="10.1177_1531003512459913-table1.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="left"/>
</colgroup>
<thead>
<tr>
<th/>
<th align="center">Group A; n (%)</th>
<th align="center">Group B; n (%)</th>
<th align="center"><italic>P</italic></th>
</tr>
</thead>
<tbody>
<tr>
<td>Symptoms</td>
<td>24 (23.5)</td>
<td>181 (37.7)</td>
<td>NS</td>
</tr>
<tr>
<td>Males</td>
<td>67 (65.7)</td>
<td>342 (71.2)</td>
<td>NS</td>
</tr>
<tr>
<td>COPD</td>
<td>40 (39.2)</td>
<td>198 (41.2)</td>
<td>NS</td>
</tr>
<tr>
<td>MI</td>
<td>32 (31.3)</td>
<td>87 (18.1)</td>
<td>NS</td>
</tr>
<tr>
<td>Hypertension</td>
<td>68 (66.7)</td>
<td>285 (42.7)</td>
<td>NS</td>
</tr>
<tr>
<td>Diabetes</td>
<td>28 (27.4)</td>
<td>101 (21.1)</td>
<td>NS</td>
</tr>
<tr>
<td>Smoke (previous or active)</td>
<td>52 (50.9)</td>
<td>220 (45.8)</td>
<td>NS</td>
</tr>
<tr>
<td>Median age in years (range)</td>
<td>82.5 (80.0-99.7)</td>
<td>65.4 (49.4-79.9)</td>
<td>&lt;.001</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn1-1531003512459913">
<p>Abbreviations: NS, not significant; COPD, chronic obstructive pulmonary disease; MI, myocardial infarction.</p></fn>
</table-wrap-foot>
</table-wrap>
<p>Indications for stenting included restenosis after endarterectomy in 12 patients (11.7%) and in-stent restenosis in 4 patients (3.9%); in the remaining patients CAS was preferred to carotid endarterectomy because of high surgical risk. The procedure was completed in 101 patients (99.0%). In one patient, the procedure was aborted because selective catheterization of the stenosed internal carotid artery was not possible. Intraoperative data of both groups of patients are shown in <xref ref-type="table" rid="table2-1531003512459913">Table 2</xref>.</p>
<table-wrap id="table2-1531003512459913" position="float">
<label>Table 2.</label>
<caption>
<p>Intraoperative Data</p>
</caption>
<graphic alternate-form-of="table2-1531003512459913" xlink:href="10.1177_1531003512459913-table2.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="left"/>
</colgroup>
<thead>
<tr>
<th/>
<th align="center">Group A</th>
<th align="center">Group B</th>
<th align="center"><italic>P</italic></th>
</tr>
</thead>
<tbody>
<tr>
<td>Median duration of CAS in minutes (range)</td>
<td>40 (20-120)</td>
<td>40 (15-125)</td>
<td>NS</td>
</tr>
<tr>
<td>Median time of administration of X-rays in minutes (range)</td>
<td>27 (9-101)</td>
<td>25 (9-95)</td>
<td>NS</td>
</tr>
<tr>
<td>Use of EPD; n (%)</td>
<td>92 (91.1)</td>
<td>413 (86.1)</td>
<td>NS</td>
</tr>
<tr>
<td>Primary stenting; n (%)</td>
<td>95 (94.0)</td>
<td>457 (95.2)</td>
<td>NS</td>
</tr>
<tr>
<td>Occurrence of bradycardia/asystole during CAS; n (%)</td>
<td>12 (11.7)</td>
<td>3 (0.6)</td>
<td>&lt;.001</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn2-1531003512459913">
<p>Abbreviations: CAS, carotid artery stenting; NS, not significant; EPD, embolic protection device.</p></fn>
</table-wrap-foot>
</table-wrap>
<p>During carotid artery dilatation or stent deployment, 12 patients (11.9%) suffered asystole/severe bradycardia, which was resolved with administration of 1 mg of atropine (11 patients) or a precordial chest thump alone (1 patient).</p>
<p>At 30 days, 2 patients (1.9%) had ipsilateral major strokes, 2 had minor strokes (1.9%), and 1 had transient ischemic attack (0.9%; <xref ref-type="table" rid="table3-1531003512459913">Table 3</xref>). We did not observe any local complications.</p>
<table-wrap id="table3-1531003512459913" position="float">
<label>Table 3.</label>
<caption>
<p>Thirty-Day Complication Rates for Groups A and B (Symptomatic and Asymptomatic Patients)</p>
</caption>
<graphic alternate-form-of="table3-1531003512459913" xlink:href="10.1177_1531003512459913-table3.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="left"/>
</colgroup>
<thead>
<tr>
<th/>
<th align="center">Symptomatic Patients; n (%)</th>
<th align="center">Asymptomatic Patients; n (%)</th>
</tr>
</thead>
<tbody>
<tr>
<td colspan="3">Group A</td>
</tr>
<tr>
<td>Death</td>
<td>0 (0.0)</td>
<td>0 (0.0)</td>
</tr>
<tr>
<td>Stroke (minor, major)</td>
<td>2 (8.3)</td>
<td>2 (2.6)</td>
</tr>
<tr>
<td>TIA</td>
<td>1 (4.1)</td>
<td>0 (0.0)</td>
</tr>
<tr>
<td>MI</td>
<td>0 (0.0)</td>
<td>0 (0.0)</td>
</tr>
<tr>
<td>Combined</td>
<td>3 (12.4)</td>
<td>2 (2.6)</td>
</tr>
<tr>
<td colspan="3">Group B</td>
</tr>
<tr>
<td>Death</td>
<td>0 (0.0)</td>
<td>3 (1.0)</td>
</tr>
<tr>
<td>Stroke (minor, major)</td>
<td>1 (0.5)</td>
<td>2 (0.6)</td>
</tr>
<tr>
<td>TIA</td>
<td>2 (1.1)</td>
<td>2 (0.6)</td>
</tr>
<tr>
<td>MI</td>
<td>0 (0.0)</td>
<td>1 (0.4)</td>
</tr>
<tr>
<td>Combined</td>
<td>3 (1.6)</td>
<td>8 (2.6)</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn3-1531003512459913">
<p>Abbreviations: TIA, transient ischemic attack; MI, myocardial infarction.</p></fn>
</table-wrap-foot>
</table-wrap>
<p>At a median follow-up of 68.3 months (range 1-124.3), data were collected on all patients (100%): 62.2% ± 11.5% were alive, 93.6% ± 2.5% were free from any neurological event, 86.2% ± 6.5% were free from myocardial infarction, and 83.5% ± 6.3% were free from restenosis. Restenosis occurred more frequently at 3 years from the procedure. All patients were asymptomatic from the neurological point of view.</p>
<p>Thirty-day and long-term outcomes after CAS in patients older than 80 years (group A) were compared with those of younger patients (group B). We did not find any differences for complications between younger and older populations for 30-day outcomes and for long-term results (<xref ref-type="table" rid="table4-1531003512459913">Tables 4</xref> and <xref ref-type="table" rid="table5-1531003512459913">5</xref>).</p>
<table-wrap id="table4-1531003512459913" position="float">
<label>Table 4.</label>
<caption>
<p>Thirty-Day Outcomes</p>
</caption>
<graphic alternate-form-of="table4-1531003512459913" xlink:href="10.1177_1531003512459913-table4.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="left"/>
</colgroup>
<thead>
<tr>
<th/>
<th align="center" colspan="2">30-Day Outcomes<hr/></th>
<th/>
</tr>
<tr>
<th align="left">Complication</th>
<th align="center">Group A; n (%)</th>
<th align="center">Group B; n (%)</th>
<th align="center"><italic>P</italic></th>
</tr>
</thead>
<tbody>
<tr>
<td>Death</td>
<td>0 (0.0)</td>
<td>3 (0.6)</td>
<td>NS</td>
</tr>
<tr>
<td>Major stroke</td>
<td>2 (1.9)</td>
<td>2 (0.4)</td>
<td>NS</td>
</tr>
<tr>
<td>Minor stroke</td>
<td>2 (1.9)</td>
<td>1 (0.1)</td>
<td>NS</td>
</tr>
<tr>
<td>TIA</td>
<td>1 (0.9)</td>
<td>4 (0.8)</td>
<td>NS</td>
</tr>
<tr>
<td>MI</td>
<td>0 (0.0)</td>
<td>1 (0.1)</td>
<td>NS</td>
</tr>
<tr>
<td>Pseudoaneurysm</td>
<td>0 (0.0)</td>
<td>5 (1.0)</td>
<td>NS</td>
</tr>
<tr>
<td>Wound hematoma</td>
<td>0 (0.0)</td>
<td>1 (0.1)</td>
<td>NS</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn4-1531003512459913">
<p>Abbreviations: NS, not significant; TIA, transient ischemic attack; MI, myocardial infarction.</p></fn>
</table-wrap-foot>
</table-wrap>
<table-wrap id="table5-1531003512459913" position="float">
<label>Table 5.</label>
<caption>
<p>Long-Term Outcomes</p>
</caption>
<graphic alternate-form-of="table5-1531003512459913" xlink:href="10.1177_1531003512459913-table5.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
</colgroup>
<thead>
<tr>
<th/>
<th align="center" colspan="2">Long-Term Outcomes<hr/></th>
<th/>
</tr>
<tr>
<th/>
<th align="center">Group A; %</th>
<th align="center">Group B; %</th>
<th align="center"><italic>P</italic></th>
</tr>
</thead>
<tbody>
<tr>
<td>Alive</td>
<td>62.2 ± 11.5</td>
<td>53.5 ± 7.6</td>
<td>NS</td>
</tr>
<tr>
<td>Free from any neurological event (alive patients)</td>
<td>93.6 ± 2.5</td>
<td>97.9 ± 2.8</td>
<td>NS</td>
</tr>
<tr>
<td>Free from MI (alive patients)</td>
<td>82.6 ± 6.5</td>
<td>88.4 ± 5.9</td>
<td>NS</td>
</tr>
<tr>
<td>Free from restenosis (alive patients)</td>
<td>83.5 ± 6.3</td>
<td>92.7 ± 8.3</td>
<td>NS</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn5-1531003512459913">
<p>Abbreviations: NS, not significant; MI, myocardial infarction.</p></fn>
</table-wrap-foot>
</table-wrap>
<p>There were no predictive factors for the occurrence of complications at 30 days, neither for old nor for younger patients (<xref ref-type="table" rid="table6-1531003512459913">Table 6</xref>). On the other hand, some factors were related to the occurrence of late complications both for old and for younger patients (<xref ref-type="table" rid="table7-1531003512459913">Table 7</xref>). Remarkably, occurrence of balloon-induced bradycardia and asystole during the procedure were predictive factors for the occurrence of myocardial infarction at long term only in patients of group A (<xref ref-type="table" rid="table7-1531003512459913">Table 7</xref>).</p>
<table-wrap id="table6-1531003512459913" position="float">
<label>Table 6.</label>
<caption>
<p>Correlations Between Risk Factors and 30-Day Procedural Complications in Groups A and B</p>
</caption>
<graphic alternate-form-of="table6-1531003512459913" xlink:href="10.1177_1531003512459913-table6.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="left"/>
<col align="char" char="."/>
<col align="char" char="."/>
</colgroup>
<thead>
<tr>
<th align="left">Risk Factor</th>
<th align="center">Postprocedural Complication</th>
<th align="center"><italic>P</italic><sup><xref ref-type="table-fn" rid="table-fn7-1531003512459913">a</xref></sup> (Group B)</th>
<th align="center"><italic>P</italic><sup><xref ref-type="table-fn" rid="table-fn7-1531003512459913">a</xref></sup> (Group A)</th>
</tr>
</thead>
<tbody>
<tr>
<td rowspan="4" valign="top">Asystole/bradycardia during CAS</td>
<td>TIA</td>
<td>.2139</td>
<td>.7176</td>
</tr>
<tr>
<td>Major stroke</td>
<td>.0984</td>
<td>.5268</td>
</tr>
<tr>
<td>MI</td>
<td>.1810</td>
<td><bold>.0450</bold></td>
</tr>
<tr>
<td>Death</td>
<td>.6390</td>
<td>.9854</td>
</tr>
<tr>
<td rowspan="4" valign="top">Symptoms before CAS</td>
<td>TIA</td>
<td>.3367</td>
<td>.3236</td>
</tr>
<tr>
<td>Major stroke</td>
<td>.2006</td>
<td>.1783</td>
</tr>
<tr>
<td>MI</td>
<td>.4908</td>
<td>.6110</td>
</tr>
<tr>
<td>Death</td>
<td>.2322</td>
<td>.3774</td>
</tr>
<tr>
<td rowspan="4" valign="top">Male gender</td>
<td>TIA</td>
<td>.6157</td>
<td>.5884</td>
</tr>
<tr>
<td>Major stroke</td>
<td>.0915</td>
<td>.1705</td>
</tr>
<tr>
<td>MI</td>
<td>.3996</td>
<td>.5246</td>
</tr>
<tr>
<td>Death</td>
<td>.8957</td>
<td>.8625</td>
</tr>
<tr>
<td rowspan="4" valign="top">Duration of CAS &gt;60 minutes</td>
<td>TIA</td>
<td>.2809</td>
<td>.2498</td>
</tr>
<tr>
<td>Major stroke</td>
<td>.1652</td>
<td>.1288</td>
</tr>
<tr>
<td>MI</td>
<td>.5136</td>
<td>.6298</td>
</tr>
<tr>
<td>Death</td>
<td>.5619</td>
<td>.5206</td>
</tr>
<tr>
<td rowspan="4" valign="top">Nonuse of EPD</td>
<td>TIA</td>
<td>.2159</td>
<td>.3899</td>
</tr>
<tr>
<td>Major stroke</td>
<td>.2986</td>
<td>.4551</td>
</tr>
<tr>
<td>MI</td>
<td>.5807</td>
<td>.6714</td>
</tr>
<tr>
<td>Death</td>
<td><bold>.0371</bold></td>
<td><bold>.0131</bold></td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn6-1531003512459913">
<p>Abbreviations: CAS, carotid artery stenting; TIA, transient ischemic attack; MI, myocardial infarction; EPD, embolic protection device.</p></fn>
<fn id="table-fn7-1531003512459913">
<label>a</label>
<p>Values in boldface indicate significant <italic>P</italic> values.</p></fn>
</table-wrap-foot>
</table-wrap>
<table-wrap id="table7-1531003512459913" position="float">
<label>Table 7.</label>
<caption>
<p>Correlations Between Risk Factors and Long-Term Postprocedural Complications in Groups A and B</p>
</caption>
<graphic alternate-form-of="table7-1531003512459913" xlink:href="10.1177_1531003512459913-table7.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="left"/>
<col align="char" char="."/>
<col align="char" char="."/>
</colgroup>
<thead>
<tr>
<th align="left">Risk Factor</th>
<th align="center">Postprocedural Complication</th>
<th align="center"><italic>P</italic><sup><xref ref-type="table-fn" rid="table-fn9-1531003512459913">a</xref></sup> (Group B)</th>
<th align="center"><italic>P</italic><sup><xref ref-type="table-fn" rid="table-fn9-1531003512459913">a</xref></sup> (Group A)</th>
</tr>
</thead>
<tbody>
<tr>
<td rowspan="4" valign="top">Asystole/bradycardia during CAS</td>
<td>Major stroke</td>
<td>.7894</td>
<td>.2345</td>
</tr>
<tr>
<td>MI</td>
<td>.1810</td>
<td><bold>.0450</bold></td>
</tr>
<tr>
<td>Death</td>
<td>.0923</td>
<td>.1345</td>
</tr>
<tr>
<td>Restenosis</td>
<td>.4327</td>
<td>.7386</td>
</tr>
<tr>
<td rowspan="4" valign="top">Symptoms before CAS</td>
<td>Major stroke</td>
<td><bold>.0147</bold></td>
<td><bold>.0067</bold></td>
</tr>
<tr>
<td>MI</td>
<td>.5956</td>
<td>.5848</td>
</tr>
<tr>
<td>Death</td>
<td>.0834</td>
<td>.0753</td>
</tr>
<tr>
<td>Restenosis</td>
<td>.3995</td>
<td>.3734</td>
</tr>
<tr>
<td rowspan="4" valign="top">Male gender</td>
<td>Major stroke</td>
<td>.3512</td>
<td>.3541</td>
</tr>
<tr>
<td>MI</td>
<td>.5390</td>
<td>.5055</td>
</tr>
<tr>
<td>Death</td>
<td><bold>.0044</bold></td>
<td><bold>.0065</bold></td>
</tr>
<tr>
<td>Restenosis</td>
<td>.8469</td>
<td>.8263</td>
</tr>
<tr>
<td rowspan="4" valign="top">Duration of CAS &gt;60 minutes</td>
<td>Major stroke</td>
<td>.3676</td>
<td>.4052</td>
</tr>
<tr>
<td>MI</td>
<td>.0797</td>
<td>.1264</td>
</tr>
<tr>
<td>Death</td>
<td>.8200</td>
<td>.8222</td>
</tr>
<tr>
<td>Restenosis</td>
<td>.7914</td>
<td>.7844</td>
</tr>
<tr>
<td rowspan="4" valign="top">Nonuse of EPD</td>
<td>Major stroke</td>
<td>.5654</td>
<td>.4999</td>
</tr>
<tr>
<td>MI</td>
<td><bold>&lt;.0001</bold></td>
<td><bold>&lt;.0001</bold></td>
</tr>
<tr>
<td>Death</td>
<td>.3987</td>
<td>.3769</td>
</tr>
<tr>
<td>Restenosis</td>
<td><bold>.0008</bold></td>
<td><bold>&lt;.0001</bold></td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn8-1531003512459913">
<p>Abbreviations: CAS, carotid artery stenting; MI, myocardial infarction; EPD, embolic protection device.</p></fn>
<fn id="table-fn9-1531003512459913">
<label>a</label>
<p>Values in boldface indicate significant <italic>P</italic> values.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="section4-1531003512459913" sec-type="discussion">
<title>Discussion</title>
<p>Today in Italy, life expectancy for an average 80-year-old woman is 9.7 years and for a man it is 7.8 years.<sup><xref ref-type="bibr" rid="bibr8-1531003512459913">8</xref></sup>
</p>
<p>As observed from our results, over the years, an increasing number of patients older than 80 years have been treated for a significant carotid stenosis (<xref ref-type="fig" rid="fig1-1531003512459913">Figure 1</xref>). According to literature, these patients should be treated preferably with carotid endarterectomy.<sup><xref ref-type="bibr" rid="bibr9-1531003512459913">9</xref></sup>
</p>
<fig id="fig1-1531003512459913" position="float">
<label>Figure 1.</label>
<caption>
<p>Number of patients older than 80 years undergoing carotid artery stenting over the years</p>
</caption>
<graphic xlink:href="10.1177_1531003512459913-fig1.tif"/>
</fig>
<p>Initially, patients 80 years and older were excluded from enrollment into the NASCET and ACAS trials and were automatically considered to be candidates for carotid stenting because advanced age was thought to be a risk factor for surgery.<sup><xref ref-type="bibr" rid="bibr10-1531003512459913">10</xref>,<xref ref-type="bibr" rid="bibr11-1531003512459913">11</xref></sup> In very old patients, however, carotid stenting cannot always be performed because of the presence of significant calcification or tortuosity of the vessels.<sup><xref ref-type="bibr" rid="bibr2-1531003512459913">2</xref></sup>
</p>
<p>On one hand, some data in literature reported good results of surgery in very old patients,<sup><xref ref-type="bibr" rid="bibr9-1531003512459913">9</xref></sup> regardless of the technical possibility to perform the surgery for the anatomical conditions and comorbidities. At the same time, both randomized trials and case series such as SAPPHIRE,<sup><xref ref-type="bibr" rid="bibr12-1531003512459913">12</xref></sup> CAPTURE,<sup><xref ref-type="bibr" rid="bibr13-1531003512459913">13</xref></sup> the initial CREST lead-in phase,<sup><xref ref-type="bibr" rid="bibr14-1531003512459913">14</xref></sup> and SAPPHIRE worldwide registry<sup><xref ref-type="bibr" rid="bibr15-1531003512459913">15</xref></sup> reported age as a risk factor for postoperative stroke and mortality after CAS.</p>
<p>Bonati et al<sup><xref ref-type="bibr" rid="bibr16-1531003512459913">16</xref></sup> recently performed a pooled analysis of individual patient data from the Symptomatic Severe Carotid Stenosis trial (EVA-3S), the Stent-Protected Angioplasty versus Carotid Endarterectomy trial (SPACE), and the International Carotid Stenting Study (ICSS). They reported a 120-day stroke risk associated with stenting in patients older than 70 years of 12.0%, suggesting that carotid endarterectomy should be the option of choice for symptomatic carotid stenosis in these patients.</p>
<p>These large trials, however, have some limitations, as great variability and bias exist between them.<sup><xref ref-type="bibr" rid="bibr17-1531003512459913">17</xref></sup> As for the SAPPHIRE WW, for example, patients were treated using a single type of stent, a unique type of embolic protection device, and the procedures were performed by physicians with varying degrees of expertise.</p>
<p>Paradoxically, some individual institutional studies specifically aimed at analyzing the role of age in the carotid stenting have shown that there are no significant differences with regard to the results of CAS in the short and medium term between octogenarians and younger patients.</p>
<p>In the literature, in fact, some authors reported more favorable experiences of endovascular treatment, with promising results at 30 days and at medium term (<xref ref-type="table" rid="table8-1531003512459913">Table 8</xref>). It is therefore understandable that there is uncertainty about the indications of CAS in octogenarians. The literature, moreover, lacks data about long-term results.</p>
<table-wrap id="table8-1531003512459913" position="float">
<label>Table 8.</label>
<caption>
<p>Combined Risk of Stroke and Death in Patients Older Than 80 Years Undergoing Carotid Artery Stenting: Review of the Literature</p>
</caption>
<graphic alternate-form-of="table8-1531003512459913" xlink:href="10.1177_1531003512459913-table8.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="char" char="."/>
</colgroup>
<thead>
<tr>
<th align="left">Study</th>
<th align="center">30-Day Combined Risk of Stroke and Death; %</th>
</tr>
</thead>
<tbody>
<tr>
<td>Chrysant et al<sup><xref ref-type="bibr" rid="bibr3-1531003512459913">3</xref></sup></td>
<td>2.3</td>
</tr>
<tr>
<td>CAPTURE<sup><xref ref-type="bibr" rid="bibr13-1531003512459913">13</xref></sup></td>
<td>8.9</td>
</tr>
<tr>
<td>CAPTURE-2<sup><xref ref-type="bibr" rid="bibr18-1531003512459913">18</xref></sup></td>
<td>4.5</td>
</tr>
<tr>
<td>EXACT<sup><xref ref-type="bibr" rid="bibr19-1531003512459913">19</xref></sup></td>
<td>5.6</td>
</tr>
<tr>
<td>CREST<sup><xref ref-type="bibr" rid="bibr14-1531003512459913">14</xref></sup></td>
<td>12.1</td>
</tr>
<tr>
<td>Setacci et al<sup><xref ref-type="bibr" rid="bibr2-1531003512459913">2</xref></sup></td>
<td>2.12</td>
</tr>
<tr>
<td>ALKKCAS<sup><xref ref-type="bibr" rid="bibr20-1531003512459913">20</xref></sup></td>
<td>5.5<sup><xref ref-type="table-fn" rid="table-fn10-1531003512459913">a</xref></sup></td>
</tr>
<tr>
<td>Tailored-CASE registry<sup><xref ref-type="bibr" rid="bibr21-1531003512459913">21</xref></sup></td>
<td>2.1</td>
</tr>
<tr>
<td>Gray et al<sup><xref ref-type="bibr" rid="bibr22-1531003512459913">22</xref></sup></td>
<td>10.5 (symptomatic patients)</td>
</tr>
<tr>
<td/>
<td>4.4 (asymptomatic patients)</td>
</tr>
<tr>
<td>Bacharach et al<sup><xref ref-type="bibr" rid="bibr23-1531003512459913">23</xref></sup></td>
<td>3.8</td>
</tr>
<tr>
<td>Bonati et al<sup><xref ref-type="bibr" rid="bibr16-1531003512459913">16</xref></sup></td>
<td>12.0<sup><xref ref-type="table-fn" rid="table-fn11-1531003512459913">b</xref></sup></td>
</tr>
<tr>
<td>Grant et al<sup><xref ref-type="bibr" rid="bibr24-1531003512459913">24</xref></sup></td>
<td>2.8</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn10-1531003512459913">
<label>a</label>
<p>In-hospital events.</p>
</fn>
<fn id="table-fn11-1531003512459913">
<label>b</label>
<p>At 120 days.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>Regarding our results, we did not observe significant differences between elderly and younger patients in the neurological and cardiac complication rates at 30 days. We observed no significant differences between younger and older patients even with regard to long-term results. In particular, male gender, symptoms before intervention, and the absence of embolic protection device seemed to be risk factors for both groups of patients. Such favorable results could be explained by a careful preoperative selection among all patients, regardless of age.</p>
<p>Review of the literature suggests that carotid stenting should be performed in patients younger than 70 years of age. In our opinion, however, age alone should not be a contraindication to CAS. The only risk factor that acted differently in the elderly than in younger patients was the occurrence of bradycardia/asystole during the procedure, which seemed to be correlated with a higher incidence of myocardial infarction in the elderly at long term.</p>
<p>This association could be explained by the fact that in the elderly, the cardiac conditions and carotid sinus reflexes have a weaker balance than in younger patients; the occurrence of arrhythmia, even if for a short time, probably has a negative effect on the transient compensation. Furthermore, especially in calcified plaque from the carotid stenosis, the optimal stent expansion sometimes requires more postdilatation and therefore higher stress on carotid sinus.</p>
<p>For these reasons, in our clinical practice, we prefer not to insist on the postexpansion of the stent and are content with a functional result rather than restore the original carotid lumen.</p>
<p>The analysis of our results is limited by the fact that it compared 2 groups of patients in a retrospective nonrandomized clinical trial. This is also a report of a small number of patients when compared with other registries reported in literature (eg, CAPTURE-2),<sup><xref ref-type="bibr" rid="bibr18-1531003512459913">18</xref></sup> but the strength of our study is the long follow-up on octogenarian patients.</p>
</sec>
<sec id="section5-1531003512459913" sec-type="conclusions">
<title>Conclusion</title>
<p>In our experience, CAS can be safely performed in patients older than 80 years with severe carotid stenosis at high surgical risk, bearing in mind that they have greater risk of myocardial infarction at long term than younger patients if they experienced bradycardia/asystole during CAS. A severe preoperative selection of patients should, however, be performed regardless of age.</p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="conflict">
<label>Declaration of Conflicting Interests</label>
<p>The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.</p>
</fn>
<fn fn-type="financial-disclosure">
<label>Funding</label>
<p>The authors received no financial support for the research, authorship, and/or publication of this article.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-1531003512459913">
<label>1.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Demirel</surname><given-names>S</given-names></name>
<name><surname>Hyhlik-Dürr</surname><given-names>A</given-names></name>
<name><surname>Attigah</surname><given-names>N</given-names></name>
<name><surname>Hakimi</surname><given-names>M</given-names></name>
<name><surname>Tengg-Kobligk</surname><given-names>H</given-names></name>
<name><surname>Böckler</surname><given-names>D</given-names></name>
</person-group>. <article-title>Vascular surgery in the elderly— recommendations for clinical practice [in German]</article-title>. <source>Zentralbl Chir</source>. <year>2011</year>;<volume>136</volume>:<fpage>471</fpage>-<lpage>479</lpage>.</citation>
</ref>
<ref id="bibr2-1531003512459913">
<label>2.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Setacci</surname><given-names>C</given-names></name>
<name><surname>de Donato</surname><given-names>G</given-names></name>
<name><surname>Chisci</surname><given-names>E</given-names></name><etal/>
</person-group>. <article-title>Is carotid artery stenting in octagenarians dangerous?</article-title> <source>J Endovasc Ther</source>. <year>2006</year>;<volume>13</volume>:<fpage>302</fpage>-<lpage>309</lpage>.</citation>
</ref>
<ref id="bibr3-1531003512459913">
<label>3.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Chrysant</surname><given-names>GS</given-names></name>
<name><surname>Prabhu</surname><given-names>ST</given-names></name>
<name><surname>Tebow</surname><given-names>A</given-names></name>
<name><surname>Snowden</surname><given-names>GM</given-names></name>
</person-group>. <article-title>Safety and efficacy of carotid artery stenting in persons aged 80 years and above</article-title>. <source>Cardiovasc Revasc Med</source>. <year>2009</year>;<volume>10</volume>:<fpage>221</fpage>-<lpage>223</lpage>.</citation>
</ref>
<ref id="bibr4-1531003512459913">
<label>4.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Nano</surname><given-names>G</given-names></name>
<name><surname>Dalainas</surname><given-names>I</given-names></name>
<name><surname>Bianchi</surname><given-names>P</given-names></name><etal/>
</person-group>. <article-title>Ballooning-induced bradycardia during carotid stenting in primary stenosis and restenosis</article-title>. <source>Neuroradiology</source>. <year>2006</year>;<volume>48</volume>:<fpage>533</fpage>-<lpage>536</lpage>.</citation>
</ref>
<ref id="bibr5-1531003512459913">
<label>5.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Brott</surname><given-names>T</given-names></name>
<name><surname>Adams</surname><given-names>HP</given-names><suffix>Jr</suffix></name>
<name><surname>Olinger</surname><given-names>CP</given-names></name><etal/>
</person-group>. <article-title>Measurement of acute cerebral infarction: a clinical examination scale</article-title>. <source>Stroke</source>. <year>1989</year>;<volume>20</volume>:<fpage>864</fpage>-<lpage>870</lpage>.</citation>
</ref>
<ref id="bibr6-1531003512459913">
<label>6.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Bonati</surname><given-names>LH</given-names></name>
<name><surname>Ederle</surname><given-names>J</given-names></name>
<name><surname>McCabe</surname><given-names>DJ</given-names></name><etal/>
</person-group> <collab>CAVATAS Investigators</collab>. <article-title>Long-term risk of carotid restenosis in patients randomly assigned to endovascular treatment or endarterectomy in the Carotid and Vertebral Artery Transluminal Angioplasty Study (CAVATAS): long-term follow-up of a randomised trial</article-title>. <source>Lancet Neurol</source>. <year>2009</year>;<volume>8</volume>:<fpage>908</fpage>-<lpage>917</lpage>.</citation>
</ref>
<ref id="bibr7-1531003512459913">
<label>7.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Safian</surname><given-names>RD</given-names></name>
<name><surname>Bresnahan</surname><given-names>JF</given-names></name>
<name><surname>Jaff</surname><given-names>MR</given-names></name><etal/>
</person-group> <article-title>CREATE Pivotal Trial Investigators. Protected carotid stenting in high-risk patients with severe carotid artery stenosis</article-title>. <source>J Am Coll Cardiol</source>. <year>2006</year>;<volume>47</volume>:<fpage>2384</fpage>-<lpage>2389</lpage>.</citation>
</ref>
<ref id="bibr8-1531003512459913">
<label>8.</label>
<citation citation-type="web">
<article-title>Italian Population Lifetables</article-title>. <ext-link ext-link-type="uri" xlink:href="http://demo.istat.it/unitav/index.html">http://demo.istat.it/unitav/index.html</ext-link>. <access-date>Accessed August 23, 2012</access-date>.</citation>
</ref>
<ref id="bibr9-1531003512459913">
<label>9.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Suliman</surname><given-names>A</given-names></name>
<name><surname>Grrenberg</surname><given-names>J</given-names></name>
<name><surname>Chandra</surname><given-names>A</given-names></name>
<name><surname>Barillas</surname><given-names>S</given-names></name>
<name><surname>Iranpour</surname><given-names>P</given-names></name>
<name><surname>Angle</surname><given-names>N</given-names></name>
</person-group>. <article-title>Carotid endarterectomy as the criterion standard in high risk elderly patients</article-title>. <source>Arch Surg</source>. <year>2008</year>;<volume>143</volume>: <fpage>736</fpage>-<lpage>742</lpage>.</citation>
</ref>
<ref id="bibr10-1531003512459913">
<label>10.</label>
<citation citation-type="journal">
<collab>North American Symptomatic Carotid Endarterectomy Trial Collaborative Group</collab>. <article-title>The final results of the NASCET trial</article-title>. <source>N Engl J Med</source>. <year>1998</year>;<volume>339</volume>:<fpage>1415</fpage>-<lpage>1425</lpage>.</citation>
</ref>
<ref id="bibr11-1531003512459913">
<label>11.</label>
<citation citation-type="journal">
<collab>Study design for randomized prospective trial of carotid endarterectomy for asymptomatic atherosclerosis</collab>. <article-title>The Asymptomatic Carotid Atherosclerosis Study Group</article-title>. <source>Stroke</source>. <year>1989</year>;<volume>20</volume>:<fpage>844</fpage>-<lpage>849</lpage>.</citation>
</ref>
<ref id="bibr12-1531003512459913">
<label>12.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Gurm</surname><given-names>HS</given-names></name>
<name><surname>Yadav</surname><given-names>JS</given-names></name>
<name><surname>Fayad</surname><given-names>P</given-names></name><etal/>
</person-group> <collab>SAPPHIRE Investigators</collab>. <article-title>Long-term results of carotid stenting versus endarterectomy in high-risk patients</article-title>. <source>N Engl J Med</source>. <year>2008</year>;<volume>358</volume>:<fpage>1572</fpage>-<lpage>1579</lpage>.</citation>
</ref>
<ref id="bibr13-1531003512459913">
<label>13.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Gray</surname><given-names>WA</given-names></name>
<name><surname>Yadav</surname><given-names>JS</given-names></name>
<name><surname>Verta</surname><given-names>P</given-names></name><etal/>
</person-group>; <collab>CAPTURE Trial Collaborators</collab>. <article-title>The CAPTURE registry: predictors of outcomes in carotid stenting with embolic protection for high surgical risk patients in early post-approval setting</article-title>. <source>Catheter Cardiovasc Interv</source> <year>2007</year>;<volume>70</volume>:<fpage>1025</fpage>-<lpage>1033</lpage>.</citation>
</ref>
<ref id="bibr14-1531003512459913">
<label>14.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hobson</surname><given-names>R</given-names></name>
<name><surname>Howard</surname><given-names>VJ</given-names></name>
<name><surname>Roubin</surname><given-names>GS</given-names></name><etal/>
</person-group>; <collab>CREST Investigators</collab>. <article-title>Carotid artery stenting is associated with increased complications in octogenarians: 30-day stroke and death rates in the CREST lead-in phase</article-title>. <source>J Vasc Surg</source>. <year>2004</year>;<volume>40</volume>:<fpage>1106</fpage>-<lpage>1111</lpage>.</citation>
</ref>
<ref id="bibr15-1531003512459913">
<label>15.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Massop</surname><given-names>D</given-names></name>
<name><surname>Dave</surname><given-names>R</given-names></name>
<name><surname>Metzger</surname><given-names>C</given-names></name><etal/>
</person-group>. <article-title>Stenting and angioplasty with protection in patients at high-risk for endarterectomy: SAPPHIRE worldwide registry first 2001 patients</article-title>. <source>Catheter Cardiovasc Interv</source>. <year>2009</year>;<volume>73</volume>:<fpage>129</fpage>-<lpage>136</lpage>.</citation>
</ref>
<ref id="bibr16-1531003512459913">
<label>16.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Bonati</surname><given-names>LH</given-names></name>
<name><surname>Fraedrich</surname><given-names>G</given-names></name>
</person-group>, <collab>on behalf of the Carotid Stenting Trialists’ Collaboration</collab>. <article-title>Age modifies the relative risk of stenting versus endarterectomy for symptomatic carotid stenosis—a pooled analysis of EVA-3S, SPACE and ICSS</article-title>. <source>Eur J Vasc Endovasc Surg</source>. <year>2011</year>;<volume>41</volume>:<fpage>153</fpage>-<lpage>158</lpage>.</citation>
</ref>
<ref id="bibr17-1531003512459913">
<label>17.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Fiehler</surname><given-names>J</given-names></name>
<name><surname>Bakke</surname><given-names>SJ</given-names></name>
<name><surname>Clifton</surname><given-names>A</given-names></name><etal/>
</person-group>. <article-title>Plea of the defence-critical comments on the interpretation of EVA3S, SPACE and ICCS</article-title>. <source>Neuroradiology</source>. <year>2010</year>;<volume>52</volume>:<fpage>601</fpage>-<lpage>610</lpage>.</citation>
</ref>
<ref id="bibr18-1531003512459913">
<label>18.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Chaturvedi</surname><given-names>S</given-names></name>
<name><surname>Matsumura</surname><given-names>JS</given-names></name>
<name><surname>Gray</surname><given-names>W</given-names></name>
<name><surname>Xu</surname><given-names>C</given-names></name>
<name><surname>Verta</surname><given-names>P</given-names></name>
</person-group>, <collab>on behalf of the CAPTURE-2 Investigators and Executive Committee</collab>. <article-title>Carotid artery stenting in octogenarians: periprocedural stroke risk predictor analysis from the multicenter Carotid ACCULINK/ACCUNET Post approval Trial to Uncover Rare Events (CAPTURE-2) Clinical trial</article-title>. <source>Stroke</source>. <year>2010</year>;<volume>41</volume>:<fpage>757</fpage>-<lpage>764</lpage>.</citation>
</ref>
<ref id="bibr19-1531003512459913">
<label>19.</label>
<citation citation-type="confproc">
<person-group person-group-type="author">
<name><surname>Yadav</surname><given-names>J</given-names></name>
</person-group>. <article-title>Carotid stenting and endarterectomy for stroke prevention</article-title>. <conf-loc>Paper presented at: 16th Annual All That Jazz Cardiology Conference</conf-loc>; <conf-date>May 14, 2007</conf-date>; <conf-loc>New Orleans, LA</conf-loc>.</citation>
</ref>
<ref id="bibr20-1531003512459913">
<label>20.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Zahn</surname><given-names>R</given-names></name>
<name><surname>Ischinger</surname><given-names>T</given-names></name>
<name><surname>Hochadel</surname><given-names>M</given-names></name><etal/>
</person-group>; <collab>for the Arbeitsgemeinschaft Leitende Kardiologische Krankenhausärzte (ALKK)</collab>. <article-title>Carotid artery stenting in octogenarians: results from the ALKK Carotid Artery Stent (CAS) Registry</article-title>. <source>Eur Heart J</source>. <year>2007</year>;<volume>28</volume>:<fpage>370</fpage>-<lpage>375</lpage>.</citation>
</ref>
<ref id="bibr21-1531003512459913">
<label>21.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Cremonesi</surname><given-names>A</given-names></name>
<name><surname>Gieowarsingh</surname><given-names>S</given-names></name>
<name><surname>Spagnolo</surname><given-names>B</given-names></name><etal/>
</person-group>. <article-title>Safety,efficacy and long-term durability of endovascular therapy for carotid artery disease: the tailored-Carotid Artery Stenting Experience of a single high-volume centre (tailored-CASE Registry)</article-title>. <source>Eurointervention</source>. <year>2009</year>;<volume>5</volume>:<fpage>589</fpage>-<lpage>598</lpage>.</citation>
</ref>
<ref id="bibr22-1531003512459913">
<label>22.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Gray</surname><given-names>WA</given-names></name>
<name><surname>Chaturvedi</surname><given-names>S</given-names></name>
<name><surname>Verta</surname><given-names>P</given-names></name>
</person-group>. <article-title>Thirty day outcomes for carotid artery stenting in 6320 patients from 2 prospective, multicenter, high-surgical-risk registries</article-title>. <source>Circ Cardiovasc Interv</source> <year>2009</year>;<volume>2</volume>:<fpage>159</fpage>-<lpage>166</lpage>.</citation>
</ref>
<ref id="bibr23-1531003512459913">
<label>23.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Bacharach</surname><given-names>JM</given-names></name>
<name><surname>Slovut</surname><given-names>DP</given-names></name>
<name><surname>Ricotta</surname><given-names>J</given-names></name>
<name><surname>Sullivan</surname><given-names>TM</given-names></name>
</person-group>. <article-title>Octogenarians are not at increased risk for periprocedural stroke following carotid artery stenting</article-title>. <source>Ann Vasc Surg</source>. <year>2010</year>;<volume>24</volume>:<fpage>153</fpage>-<lpage>159</lpage>.</citation>
</ref>
<ref id="bibr24-1531003512459913">
<label>24.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Grant</surname><given-names>A</given-names></name>
<name><surname>White</surname><given-names>C</given-names></name>
<name><surname>Ansel</surname><given-names>G</given-names></name>
<name><surname>Bacharach</surname><given-names>M</given-names></name>
<name><surname>Metzger</surname><given-names>C</given-names></name>
<name><surname>Velez</surname><given-names>C</given-names></name>
</person-group>. <article-title>Safety and efficacy of carotid artery stenting in the very elderly</article-title>. <source>Catheter Cardiovasc Interv</source>. <year>2010</year>;<volume>75</volume>:<fpage>651</fpage>-<lpage>655</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>